Bioverativ Inc.
Bioverativ Inc., a leading biotechnology company headquartered in the United States, focuses on developing innovative therapies for patients with rare blood disorders, particularly haemophilia. Founded in 2017, Bioverativ has quickly established itself in the biopharmaceutical industry, achieving significant milestones such as the successful launch of its flagship products, Eloctate and Alprolix, which offer extended protection for individuals with haemophilia A and B.
With a commitment to advancing treatment options, Bioverativ's unique approach combines cutting-edge science with patient-centric solutions, positioning the company as a key player in the global market. The firm operates primarily in North America and Europe, striving to improve the quality of life for those affected by these conditions. Through its dedication to research and development, Bioverativ continues to make notable contributions to the field of haemophilia care.
+62 vs industry average
Bioverativ Inc.’s score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Bioverativ Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Reported emissions
No reported emissions data is available for Bioverativ Inc. yet.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Bioverativ Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Bioverativ Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative
Inherited from Sanofi
Carbon Disclosure Project
Inherited from SanofiThe Climate Pledge
UN Global Compact Climate Champions initiative
Inherited from SanofiRE 100
Inherited from SanofiClimate Action 100
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project